HCAT vs SOPH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

HCAT

44.4
AI Score
VS
HCAT Wins

SOPH

42.2
AI Score

Investment Advisor Scores

HCAT

44score
Recommendation
HOLD

SOPH

42score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric HCAT SOPH Winner
Forward P/E 10 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -12.7% 27.2% SOPH
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 44.4/100 42.2/100 HCAT
Profit Margin -90.6% -93.9% HCAT
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

HCAT 1M: -0.6% · 3M: -18.3% SOPH 1M: -4.7% · 3M: +50.1%

Current Technical Phase

HCAT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.4 · Price: $1.70

SOPH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 49.5 · Price: $8.03

Fundamentals Snapshot

Metric HCAT SOPH
Market Cap — —
Forward P/E 226.7 -16.1
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.1% 0.3%
Gross Margin 0.5% 0.7%
Operating Margin -0.1% -0.9%
EPS -3.73 -1.17
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, HCAT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.